[MOL] Morning News - Much Going on with-in the biotechnology companies [00253] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Morning News - Much Going on with-in the biotechnology companies



Top Biotechnology Companies
------------------------------------------------------------------------
>>  Boehringer Ingelheim and Affymetrix Sign GeneChip(R) EasyAccess(TM)
    Silver Agreement
    Affymetrix, Inc., announced today that the Company has entered into
    an EasyAccess Silver agreement with Boehringer Ingelheim, an
    internationally operating pharmaceutical company with headquarters
    in Germany. Under the terms of the agreement ... [PR Newswire]

>>  Protein Design Labs Announces Agreement With Fujisawa
    Protein Design Labs, Inc. today announced that it has entered into
    a research agreement with Fujisawa Pharmaceutical Co., Ltd. to
    engineer certain antibodies targeted to the treatment of
    inflammatory and immunologically-mediated diseases. [PR Newswire]

>>  Base4 Receives Market Exclusivity from Open Text; Base4's
    PharMatrix Product Manages Pharmaceutical R&D Knowledge Building on
    Open Text's Livelink
    Base4 Bioinformatics Inc. announced today that it has signed an
    agreement with Open Text Corporation to be the exclusive vendor of
    Open Text's Livelink technology to the R&D organizations of
    companies in the pharmaceutical sector. [Business Wire]

>>  U.S. Patent Granted for Cyclacel's Penetratin(TM)
    Cyclacel Limited, the UK-based cancer therapeutics company,
    announced today that they have been granted United States Patent
    claiming the composition of matter known as Penetratin , a
    versatile, endonuclear drug delivery technology. [PR Newswire]

>>  Emisphere Technologies, Inc. Announces Restructuring of
    Relationship with Elan Corporation for Development and Marketing of
    Oral Heparin
    Emisphere Technologies, Inc. today announced it has agreed with
    Elan Corporation, plc to restructure their 50-50 joint venture to
    develop and market oral forms of heparin. [PR Newswire]

>>  Analitica Exhibits Latest Launches in Laboratory Analysis
    It happens in Sao Paulo, from July 6 through 8, Analitica -- the
    largest and most specific supplier's exposition for the laboratory
    industry in Latin America. [PR Newswire]

>>  sturza's medical investment letter announces investment opinion
    Sturza's Medical Investment Letter, a New York-based equity
    research company specializing in medical technology, announced
    today that Sturza's Model Portfolio appreciated 19.6% for the first
    half of 1999; for the quarter ended June 30, 1999, Sturza's
    Portfolio appreciated 11.7%. [Business Wire]

>>  Sofinov Invests in Chromos Molecular Systems Inc., a Company that
    Produces Artificial Chromosomes
    Sofinov, a subsidiary of the Caisse de depot et placement du
    Quebec, is pleased to announce $4-million investment in Chromos
    Molecular Systems inc., a company that produces artificial
    chromosomes, also called SATACs , which can contain up to 100 times
    as much DNA as commonly used [Canada Newswire